Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma

Dinesh Babu Somasundaram ¹Andrew Maher ¹Sheeja Aravindan ²Zhongxin Yu ³Brian M.Besch ³Natarajan Aravindan⁴

扫码查看

作者信息

1. Department of Radiation Oncology,University of Oklahoma Health Sciences Center,Oklahoma City,OK,USA
2. Stephenson Cancer Center,Oklahoma City,OK,USA
3. Department of Pathology,University of Oklahoma Health Sciences Center,Oklahoma City,OK,USA
4. Department of Radiation Oncology,University of Oklahoma Health Sciences Center,Oklahoma City,OK,USA;Stephenson Cancer Center,Oklahoma City,OK,USA;Department of Pathology,University of Oklahoma Health Sciences Center,Oklahoma City,OK,USA;Radiation Biology Laboratory,University of Oklahoma Health Sciences Center,BSEB 302F,941 Stanton L.Young Boulevard,Oklahoma City,OK 73104,USA
折叠

Oklahoma Center for the Advancement of Science and Technology(OCAST-HR19-045)

Department of Defense,DoD Peer Reviewed Cancer Research Program(CA-210339)

美国国立卫生研究院项目(P20GM103639)

National Cancer Institute Cancer Center Support Grant(P30CA225520)

Oklahoma Tobacco Settlement Endowment Trust(R23-03)

2024

世界儿科杂志(英文版)

CSTPCD

ISSN：

参考文献量20

段落导航